TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  Investing.com

These Surging Dividend Stocks Are the Next AI Winners and Wall Street Hates Them

Investing.com Logo Investing.com By Brett Owens
These Surging Dividend Stocks Are the Next AI Winners and Wall Street Hates Them

The article highlights two investment opportunities in the pharmaceutical and medical device sectors that could benefit from AI-driven drug development: Becton Dickinson (BDX) and the BlackRock Health Sciences Fund (BME), both currently undervalued and offering attractive dividend yields.

Insights
MSpO   neutral

Standard investment activity with no extraordinary market impact


BDX   positive

Positioned to benefit from AI-driven drug research, merging with Waters Corporation, expected to generate cash through buybacks, and has a strong dividend foundation with only 45% of free cash flow used for payouts